Abstract
Background
Livedoid vasculopathy (LV) is a chronic dermatosis associated with micro-thrombosis of the vessels of the dermis, leading to ischemic lesions and painful skin ulcerations of the lower limbs. This thrombosing occlusive vasculopathy, clearly distinct from ‘classical vasculitis’ (not related to alteration of vessel walls), may lead to peripheral neuropathy.
Objective
To clarify the main clinical, electrophysiological and pathological characteristics of peripheral neuropathy linked to LV.
Method
We presented a series of personal cases of peripheral neuropathy due to LV. We also conducted a review of the literature (since the first description of LV in 1974) using multiple combinations of keywords from ‘PubMed’, ‘Google Scholar’ and ‘ScienceDirect’ databases according to the ‘Preferred Reporting Items for Systematic reviews and Meta-Analyses’ guidelines.
Results
We identified 16 patients (6 personal cases and 10 cases from the medical literature). Our personal cases were five females and one male, with a median age (at the onset of cutaneous signs of LV) of 38 (range 25–62). Several types of skin lesions of the lower limbs were observed. Median age at the onset of peripheral neuropathy symptoms was 48 years (range 29–66), with a main clinical and electrophysiological pattern of mononeuropathy multiplex.
Discussion
We observed a typical pattern of peripheral neuropathy, mostly mononeuropathy multiplex, whose pathophysiology might be related to occlusions of the small vessels of the nerves, as seen in the dermis. Moreover, LV may also be associated with other types of peripheral neuropathies (sometimes of autoimmune etiology) not directly related to the skin lesions.
Conclusion
The ‘ischemic form’ of peripheral neuropathy linked to LV is mainly responsible for sensory disturbances (with multifocal distribution), sometimes for motor disturbances. This type of peripheral neuropathy has to be distinguished from ‘classical vasculitic neuropathies’ which are usually treated with antithrombotic therapies.
Similar content being viewed by others
Abbreviations
- CIDP:
-
Chronic inflammatory demyelinating polyradiculoneuropathy
- cPAN:
-
Cutaneous polyarteritis nodose
- HES:
-
Hematoxylin–eosin-saffron
- Ig:
-
Immunoglobulin
- IVIg:
-
Intravenous immunoglobulin
- LV:
-
Livedoid vasculopathy
- LV-PN:
-
Peripheral neuropathy due to livedoid vasculopathy
- MF:
-
Myelinated fibers
- MM:
-
Mononeuropathy multiplex
- MTHFR:
-
Methylenetetrahydrofolate reductase
- NB:
-
Nerve biopsy
- PAN:
-
Polyarteritis nodosa
- PAS:
-
Periodic Acid-Schiff
- PN:
-
Peripheral neuropathy
References
Criado PR, Rivitti EA, Sotto MN, de Carvalho JF (2011) Livedoid vasculopathy as a coagulation disorder. Autoimmun Rev 10(6):353–360
Alavi A, Hafner J, Dutz JP, Mayer D, Sibbald RG, Criado PR, Senet P, Callen JP, Phillips TJ, Romanelli M, Kirsner RS (2013) Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach. J Am Acad Dermatol 69(6):1033-1042 e1
Tran MD, Bécherel PA, Cordel N, Piette JC, Frances C (2001) Atrophie blanche “idiopathique.” Ann Dermatol Venereol 128(10 Pt 1):1003–1007
Shornick JK, Nicholes BK, Bergstresser PR, Gilliam JN (1983) Idiopathic atrophie blanche. J Am Acad Dermatol 8(6):792–798
Toth C, Trotter M, Clark A, Zochodne D (2003) Mononeuropathy multiplex in association with livedoid vasculitis. Muscle Nerve 28(5):634–639
Osada S, Kimura Y, Kawana S (2010) Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin. J Dermatol 37(1):98–101
Kim JE, Park SY, Sinn DI, Kim SM, Hong YH, Park KS, Sung JJ, Lee KW (2011) Ischemic neuropathy associated with livedoid vasculitis. J Clin Neurol 7(4):233–236
Tubone MQ, Escobar GF, Peruzzo J, Schestatsky P, Maldonado G (2013) Livedoid vasculopathy associated with peripheral neuropathy: a report of two cases. An Bras Dermatol 88(6 Suppl 1):227–229
Pai BS, Pai K (2013) Livedoid vasculopathy and mononeuritis multiplex, with a fulminant hepatic failure which was caused by herpes simplex hepatitis: a case report. J Clin Diagn Res 7(5):921–923
Maisonobe T, Allenbach Y, Barète S (2014) Une nouvelle cause de « multinévrite » sensitive: la vasculopathie livédoïde. Lettr Neurol Nerf Muscle 18(10):391–393
Malaguti MC, Cavallaro T, Speziali L, Zorzi MG, Marangoni S, Morini A (2015) Mononeuritis multiplex associated with primary livedoid vasculopathy: neuropathological evidence of ischemic nerve damage. J Neurol Sci 351(1–2):214–215
Alix JJ, Hadjivassiliou M, Ali R, Slater D, Messenger AG, Rao DG (2015) Sensory ganglionopathy with livedoid vasculopathy controlled by immunotherapy. Muscle Nerve 51(2):296–301
Allenbach Y, Tourte M, Stenzel W, Goebel HH, Maisonobe T, Frances C, Barete S, Benveniste O (2015) Expanding the spectrum of livedoid vasculopathy: peculiar neuromuscular manifestations. Neuropathol Appl Neurobiol 41(6):849–852
Corral I, Kawiorski MM, Moreno C, Pian H (2020) Vasculitic mononeuritis multiplex associated with livedoid vasculopathy. Neurologia 35(8):616–617
Winkelmann RK, Schroeter AL, Kierland RR, Ryan TM (1974) Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo Clin Proc 49(10):746–750
Mimouni D, Ng PP, Rencic A, Nikolskaia OV, Bernstein BD, Nousari HC (2003) Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 148(4):789–794
Gan EY, Tang MB, Tan SH, Chua SH, Tan AW (2012) A ten-year retrospective study on livedo vasculopathy in Asian patients. Ann Acad Med Singap 41(9):400–406
Monshi B, Posch C, Vujic I, Sesti A, Sobotka S, Rappersberger K (2014) Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients. J Am Acad Dermatol 71(4):738–744
Gardette E, Moguelet P, Bouaziz JD, Lipsker D, Dereure O, Le Pelletier F, Lok C, Maisonobe T, Bessis D, Conard J, Frances C, Barete S (2018) Livedoid vasculopathy: a French observational study including therapeutic options. Acta Derm Venereol 98(9):842–847
Weishaupt C, Strolin A, Kahle B, Kreuter A, Schneider SW, Gerss J, Eveslage M, Drabik A, Goerge T (2019) Characteristics, risk factors and treatment reality in livedoid vasculopathy—a multicentre analysis. J Eur Acad Dermatol Venereol 33(9):1784–1791
Criado PR, Pagliari C, Morita T, Marques GF, Pincelli TPH, Valente NYS, Garcia MSC, de Carvalho JF, Abdalla BMZ, Sotto MN (2021) Livedoid vasculopathy in 75 Brazilian patients in a single-center institution: clinical, histopathological and therapy evaluation. Dermatol Ther 34(2):e14810
Krueger S, McLean R, Amano S, Belazarian L (2020) Primary livedoid vasculopathy associated with mononeuritis multiplex. Dermatol Online J 26(7)
Collins MP (2012) The vasculitic neuropathies: an update. Curr Opin Neurol 25(5):573–585
Llamas-Velasco M, Alegria V, Santos-Briz A, Cerroni L, Kutzner H, Requena L (2017) Occlusive nonvasculitic vasculopathy. Am J Dermatopathol 39(9):637–662
Mathis S, Duchenne M, Magy L, Vallat JM (2020) Peripheral nervous system involvement in vasculitis. In: Rajabally YA (ed) Dysimmune neuropathies. Academic Press, London, pp 145–176
Mathis S, Magy L, Le Masson G, Richard L, Soulages A, Sole G, Duval F, Ghorab K, Vallat JM, Duchesne M (2018) Value of nerve biopsy in the management of peripheral neuropathies. Expert Rev Neurother 18(7):589–602
Hairston BR, Davis MD, Pittelkow MR, Ahmed I (2006) Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 142(11):1413–1418
Khenifer S, Thomas L, Balme B, Dalle S (2010) Livedoid vasculopathy: thrombotic or inflammatory disease? Clin Exp Dermatol 35(7):693–698
Said G, Lacroix-Ciaudo C, Fujimura H, Blas C, Faux N (1988) The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann Neurol 23(5):461–465
Ishibashi M, Miyamoto J, Nagasaka T, Chen KR (2009) Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder? Am J Dermatopathol 31(3):293–296
Karadag O, Jayne DJ (2018) Polyarteritis nodosa revisited: a review of historical approaches, subphenotypes and a research agenda. Clin Exp Rheumatol 111(2):135–142
Micieli R, Alavi A (2018) Treatment for livedoid vasculopathy: a systematic review. JAMA Dermatol 154(2):193–202
Kim EJ, Yoon SY, Park HS, Yoon HS, Cho S (2015) Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review. Dermatol Ther 28(5):287–290
Mathis S, Duval F, Soulages A, Sole G, Le Masson G (2020) The ataxic neuropathies. J Neurol 268:1365
Funding
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.
Ethical standards
This study was in compliance with the ethical principles of the conference of Helsinki.
Rights and permissions
About this article
Cite this article
Soulages, A., Maisonobe, T., Auzou, P. et al. Peripheral neuropathy and livedoid vasculopathy. J Neurol 269, 3779–3788 (2022). https://doi.org/10.1007/s00415-022-11007-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-022-11007-z